Engineered blood and lymphatic capillaries in 3‐D VEGF‐fibrin‐collagen matrices with interstitial flow
暂无分享,去创建一个
[1] B. Kudryk,et al. Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments. , 1999, Biochemistry.
[2] M. Neeman,et al. Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin. , 2002, Cancer research.
[3] J. Hubbell,et al. Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating αvβ3-integrin and activating VEGF-R2 , 2004 .
[4] M. Swartz,et al. Characterization of lymphangiogenesis in a model of adult skin regeneration. , 2006, American journal of physiology. Heart and circulatory physiology.
[5] Hung V. Nguyen,et al. The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*) , 1996, The Journal of Biological Chemistry.
[6] G. Laurent,et al. Fibrinogen , 1968, Reactions Weekly.
[7] S. Albelda,et al. Identification and characterization of cell-substratum adhesion receptors on cultured human endothelial cells. , 1989, The Journal of clinical investigation.
[8] Léone Tranqui,et al. The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors , 2004, Angiogenesis.
[9] J. Hubbell,et al. Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2. , 2004, Microvascular research.
[10] J. A. Sjøland. A new optimized method for the determination of fibrin clot permeability , 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[11] Kayla J Bayless,et al. Molecular basis of endothelial cell morphogenesis in three‐dimensional extracellular matrices , 2002, The Anatomical record.
[12] C. Jackson,et al. Human endothelial gelatinases and angiogenesis. , 2001, The international journal of biochemistry & cell biology.
[13] Jeffrey A. Hubbell,et al. Cell-Demanded Liberation of VEGF121 From Fibrin Implants Induces Local and Controlled Blood Vessel Growth , 2004, Circulation research.
[14] A. Singer,et al. Cutaneous wound healing. , 1999, The New England journal of medicine.
[15] Melody A. Swartz,et al. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro , 2005, Journal of Cell Science.
[16] R. Clark,et al. Fibrin and Collagen Differentially Regulate Human Dermal Microvascular Endothelial Cell Integrins: Stabilization of αv/β3 mRNA by Fibrin1 , 1999 .
[17] P. Koolwijk,et al. Role of Fibrin Matrix in Angiogenesis , 2001, Annals of the New York Academy of Sciences.
[18] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[19] Martin Ehrbar,et al. Cell‐demanded release of VEGF from synthetic, biointeractive cell‐ingrowth matrices for vascularized tissue growth , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] D. Kohane,et al. Engineering vascularized skeletal muscle tissue , 2005, Nature Biotechnology.
[21] Melody A. Swartz,et al. Interstitial Flow as a Guide for Lymphangiogenesis , 2003, Circulation research.
[22] Lucie Germain,et al. In vitro reconstruction of a human capillary‐like network in a tissue‐engineered skin equivalent , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] J. Hubbell,et al. Covalently conjugated VEGF--fibrin matrices for endothelialization. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[24] N. Skelton,et al. Heparin-binding Domain from Vascular Endothelial Growth Factor , 2002 .
[25] R K Jain,et al. Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[26] N. Boudreau,et al. Extracellular matrix and integrin signalling: the shape of things to come. , 1999, The Biochemical journal.
[27] John A. Pedersen,et al. Mechanobiology in the Third Dimension , 2005, Annals of Biomedical Engineering.
[28] J. Hubbell,et al. Mechanical properties, proteolytic degradability and biological modifications affect angiogenic process extension into native and modified fibrin matrices in vitro. , 2005, Biomaterials.
[29] M. P. Welch,et al. Collagen matrices attenuate the collagen-synthetic response of cultured fibroblasts to TGF-beta. , 1995, Journal of cell science.
[30] M. Swartz,et al. Fibroblast alignment under interstitial fluid flow using a novel 3-D tissue culture model. , 2003, American journal of physiology. Heart and circulatory physiology.
[31] M. Gerritsen,et al. Lumen Formation In Vivo Versus In Vitro Observations , 2003, Microcirculation.
[32] M. Pepper. Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[33] V. Nehls,et al. The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. , 1996, Microvascular research.
[34] W A Morrison,et al. Vascularisation of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states. , 2002, British journal of plastic surgery.
[35] Melody A Swartz,et al. Autologous morphogen gradients by subtle interstitial flow and matrix interactions. , 2006, Biophysical journal.
[36] Milan Mrksich,et al. Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates , 1999, In Vitro Cellular & Developmental Biology - Animal.
[37] D. Mooney,et al. Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.
[38] Lucie Germain,et al. Inosculation of Tissue‐Engineered Capillaries with the Host's Vasculature in a Reconstructed Skin Transplanted on Mice , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[39] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[40] R. Clark,et al. Fibrin and collagen differentially regulate human dermal microvascular endothelial cell integrins: stabilization of alphav/beta3 mRNA by fibrin1. , 1999, The Journal of investigative dermatology.
[41] D. Vittet,et al. In Vitro Models of Vasculogenesis and Angiogenesis , 2001, Laboratory Investigation.
[42] M. Nugent,et al. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. , 2000, Biochemistry.
[43] H. Hammes,et al. Regulation of neovascularization by human neutrophil peptides (α‐defensins): a link between inflammation and angiogenesis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] M. Skobe,et al. Molecular characterization of lymphatic endothelial cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[45] Martin Ehrbar,et al. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[46] Federica Boschetti,et al. Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[47] L. Orci,et al. Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. , 1996, Enzyme & protein.
[48] B. Keyt,et al. Solution structure of the heparin-binding domain of vascular endothelial growth factor. , 1998, Structure.
[49] Melody A Swartz,et al. Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. , 2004, Microvascular research.
[50] Dai Fukumura,et al. Engineering vascularized tissue , 2005, Nature Biotechnology.
[51] O Damour,et al. A tissue‐engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary‐like tube formation in vitro , 2003, The British journal of dermatology.
[52] L. Lorand,et al. Structural origins of fibrin clot rheology. , 1999, Biophysical journal.
[53] S. Chien,et al. Integrin-mediated mechanotransduction requires its dynamic interaction with specific extracellular matrix (ECM) ligands. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[54] J. Hubbell,et al. Effects of fibrin micromorphology on neurite growth from dorsal root ganglia cultured in three-dimensional fibrin gels. , 1998, Journal of biomedical materials research.
[55] L. Griffith,et al. Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.
[56] T. Haas. Endothelial cell regulation of matrix metalloproteinases. , 2005, Canadian journal of physiology and pharmacology.